Tetrahydrofuran → 2-{1-[4-(6-phenyl-pyrazolo[1,5-a]pyrimidin-5-yl)-benzyl]-piperidin-4-yl}-3H-imidazo[4,5-c]pyridine
반응식
[NH:1]1[CH2:6][CH2:5][CH:4]([C:7]2[NH:15][C:10]3[CH:11]=[N:12][CH:13]=[CH:14][C:9]=3[N:8]=2)[CH2:3][CH2:2]1.[C:16]1([C:22]2[C:23]([C:31]3[CH:38]=[CH:37][C:34]([CH:35]=O)=[CH:33][CH:32]=3)=[N:24][C:25]3[N:26]([N:28]=[CH:29][CH:30]=3)[CH:27]=2)[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=1.[BH-](OC(C)=O)(OC(C)=O)OC(C)=O.[Na+].C1COCC1>C(O)(=O)C>[C:16]1([C:22]2[C:23]([C:31]3[CH:32]=[CH:33][C:34]([CH2:35][N:1]4[CH2:2][CH2:3][CH:4]([C:7]5[NH:15][C:10]6[CH:11]=[N:12][CH:13]=[CH:14][C:9]=6[N:8]=5)[CH2:5][CH2:6]4)=[CH:37][CH:38]=3)=[N:24][C:25]3[N:26]([N:28]=[CH:29][CH:30]=3)[CH:27]=2)[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=1참가 물질
반응물 4
생성물 1
시약·촉매·용매 1
실험 절차
252 mg (1.06 mmol) 2-piperidine-4-yl-3H-imidazo[4,5-c]pyridine and 250 mg (0.84 mmol) 4-(6-phenylpyrazolo[1,5-a]pyrimidin-5-yl)benzaldehyde were reacted as described in example 12.0. Additional NaBH(OAc)3 has been added after one, three and five hours (two equivalents each) and the reaction mixture has been stirred overnight at room temperature. Since the reaction has not been complete, 20 mL THF and 10 mL acetic acid were added. Another two equivalents of NaBH(OAc)3 were added. Because after one hour stirring at room temperature the reaction has not changed additional 126 mg 2-piperidine-4-yl-3H-imidazo[4,5-c]pyridine and another two equivalents of NaBH(OAc)3 were added. The reaction has been worked up after stirring at room temperature for 70 hours. After purification 28 mg of the desired material has been obtained.
후처리
- stirringBecause after one hour stirring at room temperature the reaction
- stirringafter stirring at room temperature for 70 hours
- customAfter purification 28 mg of the desired material
- customhas been obtained
출처 및 근거
- ORD 기록
- ord-4a552c98376c42ea86bd641b2c3fd202
- 출처 데이터셋
- uspto-grants-2015_02
- 특허 번호
- US08957064B2
반응 노트
불러오는 중…